Innovative Approaches in Glioblastoma Treatment: The Role of Optune in Enhancing Patient Survival

References (20)

1. 1 The 2021 WHO Classification of Tumors of the Central Nervous System: a summary [DOI]
2. 2 CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018 [DOI]
3. 3 Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors [DOI]
4. 4 Incidence of gliomas by anatomic location [DOI]
5. 5 A population‐based description of glioblastoma multiforme in Los Angeles County, 1974–1999 [DOI]
6. 6 Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population [DOI]
7. 7 Cancers of the brain and CNS: global patterns and trends in incidence [DOI]
8. 8 Survival Analysis of Glioblastoma Multiforme [DOI]
9. 9 Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland [DOI]
10. 10 Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma [DOI]
11. 11 The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns [DOI]
12. 12 Long-Term Time Series Forecasting and Updates on Survival Analysis of Glioblastoma Multiforme: A 1975–2018 Population-Based Study [DOI]
13. 13 Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies [DOI]
14. 14 Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives [DOI]
15. 15 Tumor treating fields: a new approach to glioblastoma therapy [DOI]
16. 16 Synergistic effect of arsenic trioxide, vismodegib and temozolomide on glioblastoma [DOI]
17. 17 Challenges and opportunities in newly diagnosed glioblastoma in the United Kingdom: A Delphi panel [DOI]
18. 18 Molecular Docking Analysis of Bacoside A with Selected Signalling Factors Involved in Glioblastoma [DOI]
19. 19 Glioblastoma Multiforme: Molecular Biology and Updated Systematic Review on Natural Extract and Phytochemical Efficacy In-vitro [DOI]
20. 20 P01.121 Optune treatment does not affect quality of life in treatment of high grade glioma compared to chemo-radiotherapy alone [DOI]

Cited by 0

No indexed citations yet.

Related research

• Hypofractionated Radiotherapy Using Simultaneous Integrated Boost Technique with Concurrent and Adjuvant Temozolomide for Glioblastoma — shares topic coverage
• Severe and Prolonged Myelosuppression during Concomitant Temozolomide and Radiotherapy Treatment in a Patient with Glioblastoma Multiforme — shares topic coverage